Monoclonal antibody levels and protection from COVID-19
View ORCID ProfileEva Stadler, Martin T Burgess, View ORCID ProfileTimothy E Schlub, View ORCID ProfileKhai Li Chai, View ORCID ProfileZoe K McQuilten, View ORCID ProfileErica M Wood, View ORCID ProfileMark N Polizzotto, View ORCID ProfileStephen J Kent, View ORCID ProfileDeborah Cromer, View ORCID ProfileMiles P Davenport, View ORCID ProfileDavid S Khoury
doi: https://doi.org/10.1101/2022.11.22.22282199
Eva Stadler
1Kirby Institute, University of New South Wales, Sydney, Australia
Martin T Burgess
2School of Mathematics and Statistics, University of New South Wales, Sydney, Australia
Timothy E Schlub
3Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
Khai Li Chai
4Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Zoe K McQuilten
4Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
5Department of Clinical Haematology, Monash Health, Clayton, VIC, Australia
Erica M Wood
4Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
5Department of Clinical Haematology, Monash Health, Clayton, VIC, Australia
Mark N Polizzotto
6Clinical Hub for Interventional Research, College of Health and Medicine, The Australian National University, Canberra, ACT, Australia
7Department of Clinical Haematology, Canberra Region Cancer Centre, The Canberra Hospital, ACT, Australia
Stephen J Kent
8Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia
9Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia
Deborah Cromer
1Kirby Institute, University of New South Wales, Sydney, Australia
Miles P Davenport
1Kirby Institute, University of New South Wales, Sydney, Australia
David S Khoury
1Kirby Institute, University of New South Wales, Sydney, Australia
Posted December 20, 2022.
Monoclonal antibody levels and protection from COVID-19
Eva Stadler, Martin T Burgess, Timothy E Schlub, Khai Li Chai, Zoe K McQuilten, Erica M Wood, Mark N Polizzotto, Stephen J Kent, Deborah Cromer, Miles P Davenport, David S Khoury
medRxiv 2022.11.22.22282199; doi: https://doi.org/10.1101/2022.11.22.22282199
Monoclonal antibody levels and protection from COVID-19
Eva Stadler, Martin T Burgess, Timothy E Schlub, Khai Li Chai, Zoe K McQuilten, Erica M Wood, Mark N Polizzotto, Stephen J Kent, Deborah Cromer, Miles P Davenport, David S Khoury
medRxiv 2022.11.22.22282199; doi: https://doi.org/10.1101/2022.11.22.22282199
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)